UCL researchers and hospital staff with innovations that generate a social impact in healthcare are invited to apply to the Health Social Innovators’ Programme (HSI), which is now open for applications for its second intake.
HSI is a partnership between UCL Business, Healthbox, Numbers4Good and Trafford Housing Trust, with backing from the Cabinet Office’s Social Incubator Fund and Janssen Healthcare Innovation and supported by the NIHR University College London Hospitals Biomedical Research Centre (BRC), Moorfields BRC and GOSH BRC.
The programme is looking to accelerate the growth of ground-breaking, early-stage social health ventures in order to stimulate innovation and create positive change in healthcare within England.
Through a three-month customised programme, selected ventures will be provided with seed investment of up to £20,000, access to a network of over 60 outstanding mentors, tailored advice and events to present to potential customers and investors.
Among the social ventures selected to participate in last year’s programme was HeLP Diabetes, a web-based self-management programme and structured education for NHS patients with type 2 diabetes. The HeLP Digital team is a multidisciplinary group including clinicians and academics headed by Professor Elizabeth Murray, Director of the e-Health Unit, UCL Research Department of Primary Care and Population Health.
Applications for HSI are now open and will close at 12 pm on 25th September 2015. Interviews will take place in October 2015.
To apply, please visit: www.healthsocialinnovators.org
For more information, please contact Ana Lemmo Charnalia on firstname.lastname@example.org
UCL Business PLC (UCLB) is a leading technology transfer company that supports and commercialises research and innovations arising from UCL, one of the UK’s top research-led universities. UCLB has a successful track record and a strong reputation for identifying and protecting promising new technologies and innovations from UCL academics. UCLB has a strong track record in commercialising medical technologies and provides technology transfer services to UCL’s associated hospitals; University College London Hospitals, Moorfields Eye Hospital, Great Ormond Street Hospital for Children and the Royal Free London Hospital. It invests directly in development projects to maximise the potential of the research and manages the commercialisation process of technologies from laboratory to market.